ED vs RGNX · P/E 18, rev $16.92B vs rev $114.4M
Consolidated Edison Inc (ED) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported ED revenue for 2025-12-31 was $16.92B. Net income was $2.02B. Revenue was up 10.9% from 2024-12-31 to 2025-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the ED and RGNX stock pages for the full models.
Not investment advice.